Creative Details

Quality Score: 8/10

The advertisement promotes CABOMETYX as a treatment option for specific types of pancreatic neuroendocrine tumors in patients who cannot undergo surgery.

Creative Information

CID:cecea1e7-ba70-42f2-b764-51bbae460f14
CRID:82_6157-850391
Domain:exelixis.com
Seat:PP
Size:160x600
Bid:$0.30
Timestamp:11/18/2025, 10:01:33 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/19/2025, 2:26:41 AM5.79s
    adomain_analysissuccess11/19/2025, 3:08:23 AM2.84s
    adomain_capturesuccess11/19/2025, 3:08:20 AM0.12s
    ad_rendersuccess11/19/2025, 2:26:35 AM24.43s
    brand_mappingsuccess11/19/2025, 3:08:56 AM0.96s

    Analysis Results

    Ad Format: banner

    Brands: Exelixis

    Quality:Adomain not match landing page domain
    Size:160x600
    Data Transferred:1701.81 KB
    Render Time:8.74 Seconds
    Creative Inferred IAB Categories:
    • Education (IAB5)
    • Health & Fitness (IAB7)
    Creative Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Landing Page:
    Total Ad Size:1701.93 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js529.10
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/ads/studio/Enabler.js153.28
    https://s0.2mdn.net/sadbundle/11938471181016788209/img/f2-patient.png136.91
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N6246.620333PULSEPOINT/B33271959.417289989;dc_ver=106.314;dc_eid=40004001;sz=160x600;u_sd=1;gdpr_consent=AUDIT;nel=1;kw=2408841;dvs1=6157;dvs2=6157;dvs3=1;dvs4=562001;dvs5=228712;dvs6=677240;dvs7=228;dvs9=561937;dc_adk=3706686476;ord=n0lhdr;click=https%3A%2F%2Fsjc-tr.contextweb.com%2Fbh%2Fct2%3Fi%3D31NTkJl3PNDq~a%3Dbb9a3fae98d2cb59d1b8bcb4807d2d852b858ee8~agi%3D228712~ts%3Ds6YkQ5bIZS8W9mHRhf7xK_L44k8B4tKf~es%3D2~gdprc%3DCQWQbxgQWQbxgAcABBENB4FkAP_gAEPgACiQJwtR3G__bWlj-T73afpkeYxP99hrrsQxBgbJk24FzLvW_JwSx2E5NAzapqIKmRIAu3TBIQFlHIDURUCgKIgVrSDMaEyUoTNKJ6BkiBMRI2JYCFxvm4lDeQCY5vr99lcxmB-N7dr82dzyy4hHn3a5_2S1WJCdIYctDfv8ZBKT-9IEd_x8v4v4_F7gAAAAAAAAAAAAAAAAAAAAAAAAAAYJwgAmGhUQRlkQAhEoGAECABQVhABAIAgAASBogIATBgU5AwAXWEyAEAKAAYIAQAAgwABAAAJAAhEAEABAIAAIBAoAAwAIAAIACBgADABYiAQAAgOgYhAQQCBYAJGZVBpgSgAJBAS2VCCQBAgrhCEWeAQQIiYKAAAEAAoCAAB4LAQkkBKxIIAuAJgAAAAAAAAAAAAAAAAAAAAAAAAAAoAA.f_wACHwAAAAA~c%3D2408841~p%3D562001~pu%3Dhttps%253A%252F%252Fwww.travelquiz.com%252Fquiz%252F657518bfb1ab1de7ee7591f6%253Futm_source%253Ddaily%2526utm_medium%253Demail%2526utm_campaign%253D69003990c8875961bbb20075~s%3Dcontextweb.com~dt%3D5~u%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=STqGunWri8;gcsr=m;stc=1;chaa=1;sttr=96;prcl=s102.07
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://cdnjs.cloudflare.com/ajax/libs/gsap/3.9.0/gsap.min.js62.66
    https://ep1.adtrafficquality.google/bg/OUxjjEUpQOfCIZJamLGU7CrMz4_tjliTV20t0BhvBgo.js52.28
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2